Tumor necrosis factor alpha (TNF-α) is a cytokine that plays a central role in inflammation, immune system development, apoptosis, and lipid metabolism. It is mainly produced by monocytes and macrophages as a response to infection, injury, or tumor burden. TNF-α can also be produced from a range of other cell types such as T cells, natural killer cells (NK cells) and neutrophils.
This report contains market size and forecasts of GMP Tumor Necrosis Factor Alpha in Global, including the following market information:
Global GMP Tumor Necrosis Factor Alpha Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global GMP Tumor Necrosis Factor Alpha market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
25μg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of GMP Tumor Necrosis Factor Alpha include Miltenyi Biotec, Bio-Techne, GE Healthcare, Lonza, CellGenix, ReproCELL, PeproTech, Sino Biological and Creative Bioarray, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the GMP Tumor Necrosis Factor Alpha companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global GMP Tumor Necrosis Factor Alpha Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global GMP Tumor Necrosis Factor Alpha Market Segment Percentages, by Type, 2021 (%)
25μg
50μg
Others
Global GMP Tumor Necrosis Factor Alpha Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global GMP Tumor Necrosis Factor Alpha Market Segment Percentages, by Application, 2021 (%)
Cell/Gene Therapy
Tissue-Engineered Products
Others
Global GMP Tumor Necrosis Factor Alpha Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global GMP Tumor Necrosis Factor Alpha Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies GMP Tumor Necrosis Factor Alpha revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies GMP Tumor Necrosis Factor Alpha revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Miltenyi Biotec
Bio-Techne
GE Healthcare
Lonza
CellGenix
ReproCELL
PeproTech
Sino Biological
Creative Bioarray
Akron Biotech
Almog